Plasan North America nets $300 million JLTV A2 subcontract
AM General will be making tens-of-thousands of JLTVs and Plasan North America will be making subcomponents for the armoured cab. (Photo: US Army)
Plasan North America will manufacture subcomponents for the armoured cabs of AM General Joint Light Tactical Vehicles (JLTVs) under a $300 million deal announced on 17 July.
In February, AM General was awarded an $8.66 billion follow-on contract to produce up to 20,682 JLTVs and up to 9,883 trailers under JLTV A2, with initial deliveries scheduled for Q3 2024, after which trials will begin.
Government testing will be coordinated with Army Test and Evaluation Command, the Marine Corps Operational Test and Evaluation Authority and the Pentagon's Office of the Director, Operational Test and Evaluation. Locations are anticipated to be aligned with Aberdeen Proving Ground, Maryland and Yuma Proving Ground, Arizona.
Related Articles
US Army to receive first AM General JLTVs in Q3 2024
Oshkosh challenges US Army's JLTV contract decision with GAO protest
Plasan officials said the contract award would boost its workforce by 170 over the next 18 months in West Michigan, where they currently have a workforce of 80, and was the result of a 'long-standing relationship with the JLTV program, providing high-quality armour components for the last seven years'.
Related Programmes in Defence Insight
More from Land Warfare
-
AUSA 2025: KNDS France to bid for US Army requirement
The CAESAR Mk II, which was debuted internationally at Eurosatory last year, is a step up from the first model which has seen combat in Ukraine and the Middle East.
-
AUSA 2025: IAI reveals robotic route clearance system
The Elta 6631 has been developed using the experience of the Israel Defense Forces in route proving, and can be customised for various customers and circumstances.
-
AUSA 2025: Boeing wins $2.7 billion PAC-3 production contract as it explores supply chain expansion
Boeing will work with prime contractor Lockheed Martin to boost PAC-3 production capacity to hit higher delivery targets, as demand for the interceptors continues to surge.